– Reuters
MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
MaxCyte Inc (NASDAQ: MXCT) has signed a
Related Posts
AgriFORCE Reports On Ongoing Investigation Into Potentially Improper And Illegal Trading Activity In The Company’s Common Stock
AgriFORCE Growing Systems Ltd. ("the Company") (NASDAQ:AGRI, AGRIW)))), an intellectual property (IP)-focused agtech company dedicated to advancing sustainable cultivation practices and food and
Wells Fargo Maintains Overweight on LyondellBasell Industries, Raises Price Target to $97
Wells Fargo analyst Michael Sison maintains LyondellBasell Industries (NYSE:LYB) with a Overweight and raises the price target from $90 to $97.
The Green Organic Dutchman Q3 Revenue Grows 36% YoY, Here Are The Details
The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (CSE:TGOD) released its financial results for the quarter ended September 30, 2022, revealing net revenues of CA$9.92 million ($7.38 million), a 36% increase from Q3 2021.